Xianbo Zuo

7.8k total citations
95 papers, 1.0k citations indexed

About

Xianbo Zuo is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Xianbo Zuo has authored 95 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 29 papers in Molecular Biology and 17 papers in Genetics. Recurrent topics in Xianbo Zuo's work include Asthma and respiratory diseases (13 papers), Psoriasis: Treatment and Pathogenesis (12 papers) and Dermatology and Skin Diseases (12 papers). Xianbo Zuo is often cited by papers focused on Asthma and respiratory diseases (13 papers), Psoriasis: Treatment and Pathogenesis (12 papers) and Dermatology and Skin Diseases (12 papers). Xianbo Zuo collaborates with scholars based in China, United States and Germany. Xianbo Zuo's co-authors include Xuejun Zhang, Fusheng Zhou, Liangdan Sun, Sen Yang, Wei‐Dong Du, Yuan Zhou, Jian Ruan, Xiaodong Zheng, Yujun Sheng and Yong Cui and has published in prestigious journals such as SHILAP Revista de lepidopterología, Bioinformatics and PLoS ONE.

In The Last Decade

Xianbo Zuo

86 papers receiving 1000 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xianbo Zuo China 21 391 324 169 167 136 95 1.0k
Andrea‐Hermina Györfi Germany 14 422 1.1× 191 0.6× 46 0.3× 76 0.5× 66 0.5× 31 1.1k
Juehua Gao United States 16 339 0.9× 233 0.7× 122 0.7× 68 0.4× 102 0.8× 60 1.1k
Viktor Martyanov United States 21 454 1.2× 396 1.2× 75 0.4× 48 0.3× 152 1.1× 38 1.4k
Paola Pérez United States 20 556 1.4× 214 0.7× 141 0.8× 209 1.3× 113 0.8× 40 1.3k
Akihide Yoshimi Japan 23 994 2.5× 229 0.7× 106 0.6× 244 1.5× 55 0.4× 64 1.6k
Yaniv Zohar Israel 20 346 0.9× 518 1.6× 63 0.4× 102 0.6× 98 0.7× 62 1.3k
Racquel Corpuz United States 10 600 1.5× 395 1.2× 92 0.5× 115 0.7× 37 0.3× 13 1.3k
Harumi Y. Mukai Japan 19 246 0.6× 190 0.6× 61 0.4× 74 0.4× 97 0.7× 54 1.1k
Lisa Ma United States 23 493 1.3× 255 0.8× 126 0.7× 189 1.1× 43 0.3× 40 2.1k
Manuel J. Del Rey Spain 18 320 0.8× 368 1.1× 44 0.3× 135 0.8× 263 1.9× 49 1.2k

Countries citing papers authored by Xianbo Zuo

Since Specialization
Citations

This map shows the geographic impact of Xianbo Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianbo Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianbo Zuo more than expected).

Fields of papers citing papers by Xianbo Zuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianbo Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianbo Zuo. The network helps show where Xianbo Zuo may publish in the future.

Co-authorship network of co-authors of Xianbo Zuo

This figure shows the co-authorship network connecting the top 25 collaborators of Xianbo Zuo. A scholar is included among the top collaborators of Xianbo Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianbo Zuo. Xianbo Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Bo, Xiaoxue Wang, Wenqian Chen, et al.. (2024). A fully validated LC‑MS/MS method for quantifying bevacizumab in plasma samples from patients with NSCLC and its implications in therapeutic drug monitoring. Oncology Letters. 27(5). 223–223. 3 indexed citations
3.
Du, Wenwen, Xiaoxing Wang, Dan Zhang, & Xianbo Zuo. (2024). Exploratory associations of tacrolimus exposure and clinical outcomes after lung transplantation: A retrospective, single center experience. European Journal of Clinical Pharmacology. 80(5). 747–757. 2 indexed citations
4.
Qian, Junyan, Xinzhuang Yang, Jiuliang Zhao, et al.. (2023). Association Study Identified HLA‐DQA1 as a Novel Genetic Risk of Systemic Lupus Erythematosus‐Associated Pulmonary Arterial Hypertension. Arthritis & Rheumatology. 75(12). 2207–2215. 8 indexed citations
5.
Li, Bo, Wenqian Chen, Xiaoxue Wang, et al.. (2023). A fully validated method for simultaneous determination of icotinib, osimertinib, gefitinib and O-desmethyl gefitinib in human plasma using UPLC-MS/MS for therapeutic drug monitoring. Journal of Pharmaceutical and Biomedical Analysis. 236. 115697–115697. 4 indexed citations
6.
Chen, Wenqian, Xiaoxing Wang, Xiaoxing Wang, et al.. (2023). A highly sensitive method for determination of tacrolimus in peripheral blood mononuclear cells by nano liquid chromatography–high resolution accurate mass spectrometry. Journal of Chromatography A. 1706. 464259–464259. 1 indexed citations
7.
Li, Haobo, Zhu Zhang, Haoyi Weng, et al.. (2023). Proteome-wide mendelian randomization identifies causal plasma proteins in venous thromboembolism development. Journal of Human Genetics. 68(12). 805–812. 15 indexed citations
8.
Chen, Wenqian, Xiaoxue Wang, Bo Li, et al.. (2022). Effects of Voriconazole Exposure on the Pharmacokinetics of Tacrolimus in Lung Transplantation Patients, Based on Therapeutic Drug Monitoring Data. The Journal of Clinical Pharmacology. 62(10). 1310–1320. 6 indexed citations
9.
Chen, Mengyun, Wenjing Li, Xiaowei Zhang, et al.. (2020). Loss-of-function variants in FSIP1 identified by targeted sequencing are associated with one particular subtype of mucosal melanoma. Gene. 759. 144964–144964. 4 indexed citations
10.
Yang, Fan, Yan Zhang, Xing Fan, et al.. (2019). HLA-A*01:01 in MHC is associated with psoriatic arthritis in Chinese Han population. Archives of Dermatological Research. 311(4). 277–285. 11 indexed citations
11.
12.
Zuo, Xianbo, et al.. (2016). Filaggrin and pathogenesis of related skin diseases. International Journal of Dermatology and Venereology. 42(5). 427–429. 1 indexed citations
13.
Hua, Li, et al.. (2015). Four‐locus gene interaction between IL13, IL4, FCER1B, and ADRB2 for asthma in Chinese Han children. Pediatric Pulmonology. 51(4). 364–371. 17 indexed citations
14.
Wang, Xia, Yuxian Shen, Yuxian Shen, et al.. (2014). Deficiency of IRE1 and PERK Signal Pathways in Systemic Lupus Erythematosus. The American Journal of the Medical Sciences. 348(6). 465–473. 36 indexed citations
15.
Zhang, Bo, Li Yang, Longnian Li, et al.. (2014). Association study of susceptibility loci with specific breast cancer subtypes in Chinese women. Breast Cancer Research and Treatment. 146(3). 503–514. 24 indexed citations
16.
Yin, Xianyong, Nathan E. Wineinger, Hui Cheng, et al.. (2014). Common variants explain a large fraction of the variability in the liability to psoriasis in a Han Chinese population. BMC Genomics. 15(1). 87–87. 9 indexed citations
17.
Zhou, Yuan, Wei‐Dong Du, Qiang Wu, et al.. (2012). EZH2 genetic variants affect risk of gastric cancer in the Chinese Han population. Molecular Carcinogenesis. 53(8). n/a–n/a. 20 indexed citations
18.
Wu, Qiang, Gang Chen, Yuan Zhou, et al.. (2011). E‐selectin rs5361 and FCGR2A rs1801274 variants were associated with increased risk of gastric cancer in a Chinese population. Molecular Carcinogenesis. 51(8). 597–607. 20 indexed citations
19.
Zhu, Kunju, Qiang Xu, Xuejun Zhang, et al.. (2010). The association of the BLK gene with SLE was replicated in Chinese Han. Archives of Dermatological Research. 302(8). 619–624. 21 indexed citations
20.
Zheng, Hou‐Feng, Xianbo Zuo, Wensheng Lu, et al.. (2010). Variants in MHC, LCE and IL12B have epistatic effects on psoriasis risk in Chinese population. Journal of Dermatological Science. 61(2). 124–128. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea‐Hermina Györfi Breakdown of academic impact, for papers by Juehua Gao Breakdown of academic impact, for papers by Viktor Martyanov Breakdown of academic impact, for papers by Paola Pérez Breakdown of academic impact, for papers by Akihide Yoshimi Breakdown of academic impact, for papers by Yaniv Zohar Breakdown of academic impact, for papers by Racquel Corpuz Breakdown of academic impact, for papers by Harumi Y. Mukai Breakdown of academic impact, for papers by Lisa Ma Breakdown of academic impact, for papers by Manuel J. Del Rey
Rankless by CCL
2026